CIK 0001061027
VIRX Viracta Therapeutics, Inc.
Insider trading from SEC Form 4. Last filing Nov 27, 2024.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
2
with a Form 4 at this company
Signals
Open-market buys and sells at Viracta Therapeutics, Inc., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 4 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 25, 2024 | Roger Pomerantz director | MOption exercise Common Stock | +9,034 | $0.00 | $0 | 126,478 | Nov 27, 2024 |
| Nov 25, 2024 | Ivor Royston director | MOption exercise Common Stock | +25,219 | $0.00 | $0 | 839,741 | Nov 27, 2024 |
| Nov 25, 2024 | Roger Pomerantz director | MOption exercise Restricted Stock Unitsderivative | -9,034 | $0.00 | $0 | 18,069 | Nov 27, 2024 |
| Nov 25, 2024 | Ivor Royston director | MOption exercise Restricted Stock Unitsderivative | -25,219 | $0.00 | $0 | 50,438 | Nov 27, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.